Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176,366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with chemotherapy or antiangiogenic therapy as first-line treatment in patients with EGFR-mutant non-small cell lung cancer: A systematic review and meta-analysis.
Chen Y, Wen S, Wu Y, Shi L, Xu X, Shen B. Chen Y, et al. Crit Rev Oncol Hematol. 2021 Jul;163:103393. doi: 10.1016/j.critrevonc.2021.103393. Epub 2021 Jun 11. Crit Rev Oncol Hematol. 2021. PMID: 34119658 Free article. Review.
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study.
Wen S, Du X, Chen Y, Xia J, Wang R, Zhu M, Peng W, Spitaleri G, Hofman P, Bironzo P, Wang X, Shen B. Wen S, et al. Among authors: chen y. Transl Lung Cancer Res. 2022 May;11(5):757-775. doi: 10.21037/tlcr-22-300. Transl Lung Cancer Res. 2022. PMID: 35693285 Free PMC article.
Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials.
Zhou JG, Wong AH, Wang H, Jin SH, Tan F, Chen YZ, He SS, Shen G, Frey B, Fietkau R, Hecht M, Carr SR, Wang R, Shen B, Schrump DS, Ma H, Gaipl US. Zhou JG, et al. Front Immunol. 2022 Sep 2;13:961926. doi: 10.3389/fimmu.2022.961926. eCollection 2022. Front Immunol. 2022. PMID: 36119066 Free PMC article.
176,366 results
You have reached the last available page of results. Please see the User Guide for more information.